BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS(R) 2025
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS(R) 2025 GlobeNewswire November 18, 2025 Three BriaCell poster presentations include updated key biomarker data from BriaCell's pivotal Phase 3 study and updated survival data from the Phase 2 study of Bria-IMT(TM) plus immune check point inhibitor (CPI) in metastatic breast cancer PHILADELPHIA and […]